Bioethics News

Taxpayers Helped Fund This $129,000 Cancer Drug. Should the Government Help Cut the Price?

January 14, 2016

(The Washington Post) – Two nonprofit groups have petitioned the federal government to take actions to increase the competition for a cancer drug that costs $129,269 a year by exercising its right to step in if the fruits of taxpayer-funded research are not “available to the public on reasonable terms,” according to U.S. law.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.